Delhi HC: Difference in Layout is of No Consequence if Essential Feature of Trademark Infringed  ||  Allahabad HC: Parliament has Responsibility to Restrain Criminals from Entering Into Politics  ||  Delhi HC Refuses to Vacate Stay on Direction to Enforce CM's Speech Promising Rent Relief  ||  J&K&L HC: Judges Must Refrain from Making Derogatory Remarks Against Parties  ||  Delhi HC: Courts Should be Sensitive When Poor And Deprived Knock at its Doors  ||  CESTAT: Law Does Not Mandate Customs Broker to Physically Verify Address of Client  ||  Orissa HC: Appeal Can’t be Dismissed on Sole Ground of Non-Submission of Certified Order  ||  ITAT: Deposit of Banned Notes Received Out of Cash Sales During Demonetization Period is Valid  ||  ITAT: Arrangement Between Spouse Without Real Money Exchange Not Amount to Unexplained Investment  ||  ITAT: 100% Deduction U/S 80IC of IT Act allowable when Industry undergone Substantial Expansion    

Delhi High Court Refuses Interim Injunction Against RTPCR Testing Kit OMISURE - (01 Apr 2022)

INTELLECTUAL PROPERTY RIGHTS

Delhi High Court has refused to pass an ad interim injunction against Tata Medical and Diagnostics Limited, manufacturer of OMISURE, an RTPCR kit that was used to detect COVID-19 Omicron variant, in a suit filed by Mankind Pharma Limited seeking permanent injunction for infringement of trademark

Tags : DELHI HIGH COURT   AD INTERIM INJUNCTION   TATA MEDICAL AND DIAGNOSTICS LIMITED   OMISURE   COVID-19   OMICRON VARIANT   MANKIND PHARMA  

Share :        

Disclaimer | Copyright 2022 - All Rights Reserved